YOLFTbeta
Hironic Co. Ltd

Hironic Co. Ltd

149980 · KQ · Healthcare / Medical Devices

3,885.00KRW-10.00 (-0.26%)

Price History

Full chart

Market Stats

Previous Close3,895.00
Open3,930.00
Day Range3,855.00 – 3,995.00
52-Week Range3,770.00 – 9,039.05
Volume3.29K
Market Cap78.43B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield4.98%
Beta0.25
50-Day Avg4,872.30
200-Day Avg5,037.73

About

Hironic Co., Ltd. engages in the manufacture and sale of medical and surgical equipment, and other orthopedic appliances in South Korea and internationally. It offers its products for the MFU and RF, laser, plasma, and cryotherapy. The company was founded in 2007 and is headquartered in Yongin-Si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOKwang Park Seok
  • Employees0
  • HeadquartersU-Tower, Yongin-Si, South Korea, 16827, Korea
  • Websitehttps://www.hironic.com

Leadership

  • Kwang Park SeokChief Executive Officer

Financials

Income Statement

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue22.82B17.92B15.48B18.13B20.33B20.13B12.99B21.78B27.57B33.73B31.63B32.09B
Growth (%)--21.48%-13.62%+17.16%+12.11%-0.98%-35.49%+67.73%+26.57%+22.36%-6.24%+1.45%
Cost of Revenue7.55B5.89B5.54B6.26B8.40B8.13B4.92B8.55B12.69B14.54B19.40B13.18B
Gross Profit15.27B12.03B9.94B11.88B11.92B12.00B8.07B13.23B14.87B19.19B12.23B18.91B
Gross Margin66.91%67.13%64.20%65.49%58.66%59.62%62.11%60.75%53.95%56.90%38.68%58.93%
Operating Expense7.62B9.96B9.59B10.13B11.95B9.39B6.83B8.60B11.29B13.92B18.59B14.80B
Operating Income7.65B2.07B347.12M1.75B-28.35M2.61B1.24B4.63B3.58B5.27B-6.35B4.11B
Operating Margin33.52%11.53%2.24%9.64%-0.14%12.98%9.51%21.26%12.99%15.62%-20.08%12.82%
EBITDA--------5.80B11.20B-7.11B6.01B
EBITDA Margin--------21.05%33.21%-22.49%18.74%
Net Income6.45B2.83B718.71M763.25M-259.88M2.90B3.18B6.78B2.93B8.22B-7.05B3.16B
Net Income Margin28.26%15.81%4.64%4.21%-1.28%14.43%24.47%31.11%10.64%24.38%-22.28%9.85%
R&D1.36B1.90B1.74B2.92B3.11B2.33B1.97B1.49B2.35B3.23B3.42B3.41B
R&D as % of Total Revenue5.96%10.63%11.26%16.09%15.29%11.56%15.14%6.84%8.52%9.58%10.82%10.62%
Interest Expense00000058.95M10.98M117.72M420.03M46.40M33.73M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.45%0.05%0.43%1.25%0.15%0.11%

Balance Sheet

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets53.40B45.86B44.72B50.03B43.01B46.87B44.76B63.67B67.51B79.10B78.42B71.24B
Total Liabilities6.53B1.93B1.92B10.12B5.26B6.14B3.16B7.72B8.84B6.69B10.18B7.71B
Total Equity46.87B43.93B42.80B39.91B37.75B40.72B41.60B55.95B58.67B72.29B68.17B63.47B
Cash6.92B3.57B1.56B1.73B2.80B2.15B3.47B4.19B4.03B6.03B2.83B2.96B
Total Debt-----1.48B------

Cash Flow

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow5.21B315.83M500.84M1.44B-1.52B4.29B4.11B426.53M4.50B-1.14B5.52B-88.09M
Investing Cash Flow-36.11B5.58B-565.77M-2.04B9.02B-4.41B1.84B-2.04B-4.32B---
Financing Cash Flow35.73B-9.25B-1.94B767.16M-6.42B-520.86M-4.61B2.31B-78.08M---
Capital Expenditure690.98M7.79B3.22B1.08B1.79B660.23M340.80M1.57B547.19M878.38M1.87B2.36B
Free Cash Flow------3.67B-1.26B3.69B-2.02B3.64B-2.45B
Dividends Paid50.00M955.14M134.19M134.19M38.78M37.70M703.97M604.35M----
FCF to OCF------89.42%-296.01%82.01%176.79%66.02%2783.29%
Dividend Paid to FCF------19.16%-47.87%----

Earnings

Report DateFeb 13, 2015May 17, 2015Aug 18, 2015Nov 17, 2015Feb 5, 2016May 2, 2016Aug 12, 2016Nov 14, 2016Feb 23, 2017May 4, 2017Aug 14, 2017Nov 14, 2017Feb 6, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Mar 6, 2019Apr 26, 2019Jul 25, 2019Oct 22, 2019Mar 5, 2020Apr 23, 2020Aug 14, 2020Oct 27, 2020Mar 2, 2021Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------------------------------------
EPS Actual120.0043.98134.8537.85-28.2434.3019.77-62.3856.36-7.2440.0032.03-11.404.1469.89-39.54-55.0892.3785.0884.97-52.2983.64-24.5443.64128.9019.4196.64109.09189.26100.4264.92132.99-124.8314.0655.8883.49340.4248.0173.59-83.58-411.83113.16-71.2829.59139.7577.7045.53
Surprise-----------------------------------------------
TimingAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours----------------------

Key Statistics & Ratios

Market Cap78.43B
Enterprise Value59.18B
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.11
Price / Book1.02
Revenue (TTM)37.10B
Gross Profit (TTM)23.30B
EBITDA7.23B
Profit Margin12.21%
Operating Margin10.18%
Return on Equity6.32%
Return on Assets4.25%
Shares Outstanding17.20M
Shares Float6.65M
Beta0.25
Dividend Yield4.98%
Dividend Rate233.00
Payout Ratio79.64%

Dividends

20261×
233.00Jun 29, 2026
20201×
37.12Dec 29, 2020
20191×
42.42Dec 27, 2019
20181×
2.27Dec 27, 2018
20171×
2.27Dec 27, 2017
20161×
7.58Dec 28, 2016
20151×
53.03Sep 25, 2015

Stock Splits

  • Feb 7, 20246:5
  • Feb 3, 202398163:89239
  • Sep 11, 20155:1